AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2020
Feb 19, 2020
29821_dirs_2020-02-19_1ca49043-d179-46d6-b5f3-17766b9fe5cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-02-18
Reporting Person: Mackey Edward F (EVP, Operations)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-18 | Deferred Stock Units | $ | A | 23719.0000 | Acquired | 2022-02-18 | Common Stock (23719.0000) | Direct |
| 2020-02-18 | Deferred Stock Units | $ | A | 8894.0000 | Acquired | 2024-02-18 | Common Stock (8894.0000) | Direct |
| 2020-02-18 | Stock Option (Right to Buy) | $42.1600 | A | 33185.0000 | Acquired | 2030-02-18 | Common Stock (33185.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in one installment on February 18, 2022, the second anniversary of the date of grant.
F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.